Billy shares his approach to credit investments, emphasizing the importance of diversification and leveraging data as a "truth serum" to assess risk. He highlights the significance of finding niche industries with substantial book yields and the ability to control cash flow, while also discussing the challenges of underwriting well-known assets versus those with regulatory uncertainties.
